CLS is committed to providing the media with timely and accurate information related to California’s life sciences ecosystem. CLS welcomes all media inquiries from news organizations and reporters. Members of the media interested in speaking with CLS opinion leaders on issues of public policy, life sciences innovation, or issues related to the life sciences ecosystem in California, please contact our communication department.
Media Contact: [email protected]
CLS Comments on NIST Draft March-In Rights Framework
Feb 7, 2024
CLS submitted comments to the National Institute of Standards and Technology’s Request for Information on the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights. In our response,..
Read MoreCalifornia Life Sciences CEO Mike Guerra joins life sciences leaders to celebrate investment in biotech at New York Stock Exchange
Jan 3, 2024
January 3, 2024, New York, NY – California Life Sciences (CLS) joined fellow trade organizations from across the country to ring the closing bell at the New York Stock Exchange..
Read MoreOverriding patent rights will harm California’s life sciences innovation
Dec 8, 2023
December 8, 2023 California Life Sciences President & CEO Mike Guerra releases statement on Biden Administration’s Proposed Framework on March-in rights: “California Life Sciences is discouraged by the Biden administration’s..
Read MoreCalifornia Life Sciences announces 20th annual Pantheon Award winners
Nov 2, 2023
SAN FRANCISCO, Calif., Nov 2, 2023 — California Life Sciences (CLS), the state’s most impactful life sciences trade association, today announced the winners of its 20th annual Pantheon Awards. The awards celebrate..
Read More